What we mean by mold illness vs CIRS
Toxic mold exposure here means health concerns linked to damp indoor environments — not a single lab-proven poison for every reader.
CIRS (chronic inflammatory response syndrome) is a specialty / community framework used by many patients and some clinicians. It is not universally accepted medical nosology. We explain how people use the term and how to shop carefully — we do not adopt one protocol brand as Regenerated dogma.
What we do not claim: that every damp-building symptom equals CIRS, that a specialty panel alone proves a single disease, or that a regenerative protocol clears mycotoxins on demand.
Why this sits next to Lyme
Fatigue, cognitive complaints, and inflammatory shopping funnels overlap. Patients often chase both labels. Keep lanes clear: infection vs exposure vs post-infectious syndromes.
Bidirectional companion: [Lyme disease Guide](/conditions/lyme-disease). Also see [ME/CFS](/conditions/chronic-fatigue-syndrome) and [Long COVID](/conditions/long-covid) when PEM or post-viral patterns fit. Overlap is not identity.
Diagnosis and differentials
Start with exposure history (home/work) and a real differential (allergy, infection, asthma, ME/CFS/PEM pattern, other). Do not accept definitive CIRS blood panel proves X without asking sensitivity, specificity, and what changes if negative.
Document building history, symptom timeline, respiratory features, and prior treatments. Ask what would change management if specialty labs are negative or inconclusive.
Conventional / environmental baseline
Remediate or leave ongoing exposure when feasible — supplements do not replace building issues
- Allergy / ENT / pulmonary evaluation when respiratory disease is present
- Avoid jumping to multi-thousand-dollar binder stacks before exposure and differential work
This Guide does not dismiss people who feel dismissed as “just allergies.” Gaps appear when clinics skip exposure and differentials, or when marketing sells certainty where frameworks are contested.
Regenerative and integrative options — evidence-graded
Same honesty bar as the Lyme companion package. Working grades: Stronger Mixed / emerging Supportive / adjunct · Speculative / clinic-marketed. Prefer “may help some people” over “works.”
#### Supportive care — Supportive / adjunct
Sleep, pacing if PEM is present, nutrition, and autonomic-aware support may help some people. They do not replace remediation when exposure is ongoing.
Directory: [Browse clinics](/clinics)
#### Hyperbaric oxygen therapy (HBOT) — Limited
HBOT may appear in integrative mold-related shopping lists. It is not established as mycotoxin eradication. Adjunct framing only.
[HBOT treatment](/treatments/hbot) · [HBOT clinics](/clinics/t/hbot)
#### Stem cells / exosomes / peptides — Speculative / clinic-marketed
Do not accept cellular or peptide products as “mycotoxin erasers.” Treat eradication claims as high-misuse terrain.
[Stem cell therapy](/treatments/stem-cell-therapy) · [Stem cell clinics](/clinics/t/stem-cell-therapy) (listing endorsement)
#### Ozone / “detox” / binder stacks sold before remediation — Red-flag literacy
Ozone and detox marketing is a red-flag literacy topic, not a Directory endorsement. Binder + protocol stacks sold before remediation discussion deserve slow, skeptical shopping.
Primary Directory actions (required CTAs):
Find clinics browse carefully; remediation and differentials come before expensive stacks:
[Browse all clinics](/clinics) — Featured/paid placement ≠ clinical superiority
> - [Find HBOT clinics](/clinics/t/hbot) (adjunct only)
> - Companion: [Lyme disease Guide](/conditions/lyme-disease)
We do not list “best clinics” inside this Guide. `score ≠ spend`.
Red flags and shopping hazards
Walk away or slow way down — if you see:
“Spore detox cures
- Binder + protocol stacks sold before remediation discussion
- Cure guarantees for mold toxicity
- Stem cells / peptides as mycotoxin erasers
- Protocol loyalty tests
- Ignoring Lyme / post-viral / PEM differentials when history fits
- Any implication that paid Directory placement means better clinical quality
Questions to ask a clinician
Are we treating exposure-related illness, a CIRS framework, Lyme / post-infectious patterns, or an open differential?
2. What tests will you run, and what would change management if negative?
3. What is the plan for ongoing building exposure before or alongside supplements?
4. Which therapies are guideline-supported vs exploratory, and what are the risks?
5. How do you avoid endless binder/protocol stacking without stop criteria?
6. What functional outcomes define “enough improvement”?
7. How do you coordinate allergy / pulmonary care when respiratory disease is present?
Finding clinics (Directory CTA)
If you are ready to look at options, use the Directory not a Guide listicle.
**[Browse clinics ](/clinics)
[HBOT clinics →](/clinics/t/hbot)** (adjunct only)
[Lyme disease Guide ](/conditions/lyme-disease)
[ME/CFS Guide →](/conditions/chronic-fatigue-syndrome) · [Long COVID →](/conditions/long-covid)
Learn how we approach listings: [How we vet clinics](/about/how-we-vet-clinics). Featured labels, when present, are commercial chrome — not a clinical ranking.
Related reading
Sibling Guides (evergreen):
[Lyme disease](/conditions/lyme-disease) — bidirectional companion in this D-03 package
- [ME/CFS / chronic fatigue syndrome](/conditions/chronic-fatigue-syndrome)
- [Long COVID](/conditions/long-covid)
Treatments:
[HBOT](/treatments/hbot) · [Stem cell therapy](/treatments/stem-cell-therapy)
Note on `/conditions/cirs`: still 404 by design. Do not create a thin stub. Alias → mold page or future `lyme-cirs` is an Eng+SEO decision later.
Blog: news / timely only; evergreen owner is this Guide (D-02). Do not let Blog titles clone this H1.